ePoster

DISTINCT TAU ISOFORMS DIFFERENTIALLY DISRUPT AUTOPHAGY AND MITOCHONDRIAL FUNCTION: IMPLICATIONS FOR TAUOPATHIES

Ariadna Sancha Velascoand 4 co-authors

Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12 Research Institute)

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS05-09AM-220

Presentation

Date TBA

Board: PS05-09AM-220

Poster preview

DISTINCT TAU ISOFORMS DIFFERENTIALLY DISRUPT AUTOPHAGY AND MITOCHONDRIAL FUNCTION: IMPLICATIONS FOR TAUOPATHIES poster preview

Event Information

Poster Board

PS05-09AM-220

Abstract

Tauopathies comprise a heterogeneous group of neurodegenerative disorders characterized by intraneuronal accumulation of tau protein. Different tauopathies subtypes are defined by the predominant tau isoform accumulated, either 3-repeat (3R) tau, as in Pick’s disease, or 4-repeat (4R) tau, as in progressive supranuclear palsy and corticobasal degeneration. While tau accumulation is a central feature of these diseases, whether distinct tau isoforms trigger neurodegeneration through shared or isoform-specific mechanisms remains unclear. In this study, we investigated the impact of 3R and 4R tau accumulation on autophagy flux, mitochondrial homeostasis, and neuronal survival. We employed disease-in-a-dish models of tauopathies, including SH-SY5Y cells, induced pluripotent stem cell–derived neurons, and human brain organoids. Tau accumulation induced dysfunction of both autophagy and mitochondrial pathways in an isoform-dependent manner. Impaired autophagy flux was observed selectively in models accumulating 4R tau, whereas mitochondrial homeostasis was disrupted by both 3R and 4R tau isoforms. Interestingly, while tau accumulation resulted in neurotoxicity across all models, with significantly different neuronal death rates between 3R and 4R tau conditions were found. These findings indicate that distinct tau isoforms engage specific molecular pathways affecting cellular homeostasis and neuronal viability. Our results provide mechanistic insight into the clinical tauopathies heterogeneity and support the development of tau isoform-specific therapeutic strategies targeting key pathogenic processes.

Recommended posters

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.